Well, hello, hello, guys. You're listening to Beauty Bites with Dr. Kay, Secrets of a Plastic Surgeon,

and it's time for a five-minute Friday. Today, let's talk about one of my favorite topics.

It's semi-glutide shots, and what are the new miraculous things that we are learning about the power of

these shots to not only give you weight loss, but potentially improve reproductive,

fertility issues, neurologic issues. This is amazing. Let's talk about breakthrough treatments and

new possibilities for semi-glutides. Now, you know that I'm a huge fan of semaglutides. I feel like we talked about it first a year ago, more than a year ago on this podcast with Dr. Danielle Bellardo, who's been one of the weight loss pioneers. I am definitely someone who's a fan and a believer. I've lost a good 25 pounds with some glutite shots. I did Wagovi.

You might have heard of other ones. Monjaro is excellent. Trizepotite is excellent. And sometimes

metabolic changes just cannot be conquered with dietary restrictions alone, exercise alone.

Those of you who can do it on your own, great. Those of you who need help

and assistance, guess what? When metabolic changes happen, perimenopause happens, that visceral

fat around the organs, the centripetal body fat that turns you from an hourglass into a rectangle,

there are things you can do. And OZempic is revolutionary. The whole world was

talking about it, primarily for use in diabetes, and then it was discovered to shed excess body

fat so amazingly. The GLP1 medications, that's glucagon like peptide one receptor agonists that's a mouthful glpc1

glucocon like peptide one receptor agonists these are molecules that are going to improve weight

loss for sure diabetic function for sure secretion of of insulin, regulation of blood sugar. But guess what?

GLP-1 medications now are proposed and reported to potentially benefit hormone disorders like polycystic

ovarian syndrome, cognitive disorders like Alzheimer's, Parkinson's, and even multiple sclerosis.

We are noticing clinically in so many fields that the GLP1 agonists have multiple, multiple benefits.

OZMPIC's popularity is showing no signs of slowing down. It's going to continue to dominate the weight loss industry in

2024 and growth in sales is increased by 23% from 2023 to 24 and now has reached up to 12.5 billion

dollars. Guess what? By 2030 this market's going to hit 100 billion dollars. So if you're in the

...